Venlafaxine
| Venlafaxine | |
|---|---|
| Salts [] | |
|---|---|
| Venlafaxine besylate | |
| Venlafaxine hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 277.40 g/mol [1] |
| Melting point | Crystals from ethyl acetate; melting point 102-104 °C; specific optical rotation: +27.6 deg (c = 1.07 in 95% ethanol) /Venlafaxine (+)form/ [1] |
| Solubility | 572 mg/mL [1] |
| Predicted LogP | 2.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H27NO2 |
| IUPAC name | 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol |
| SMILES | CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O |
| InChI | InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3 |
| InChIKey | PNVNVHUZROJLTJ-UHFFFAOYSA-N |
| CAS number | 93413-69-5 |
| UNII | GRZ5RCB1QG |
| PubChem CID | 5656 |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 5±2 h (parent compound for immediate release preparations), 15±6 h (parent compound for extended-release preparations), 11±2 h (active metabolite) |
| Metabolism | Extensively metabolised by the liver, primarily via CYP2D6[3] |
| Excretion | Kidney (87%; 5% as unchanged drug; 29% as desvenlafaxine and 53% as other metabolites) |
| Routes of administration | Oral |
| Dosing[] |
|---|
| Oral [] | |
|---|---|
| Threshold | 20 - 37.5 |
| Light | 37.5 - 56.25 |
| Common | 56.25 - 75 |
| Strong | 75 - 131.25 |
| Heavy | 131.25 - 150 |
Statistically derived dosages via DBI-IGS (archived by anodyne.wiki) We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Venlafaxine (also known as Venlafaxina, Elafax, Venlafaxinum, Trevilor, velafax, Venlafexine, Efectin, Kanghong, Venlor or Efexor) is a serotonin-norepinephrine reuptake inhibitor substance of the phenethylamine class.
Chemistry
Salts []
Stereochemistry []
Venlafaxine is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Venlafaxine matches Lipinski's rule of five.Pharmacology
ATC Classification
- nervous system (N)
- psychoanaleptics (N06)
- antidepressants (N06A)
- other antidepressants (N06AX)
- (N06AX16)
- venlafaxine (N06AX16)
MeSH Classification
- serotonin and noradrenaline reuptake inhibitors (M000603649)
- antidepressive agents, second-generation (M0028000)
Mechanism of action []
The exact mechanism of action of venlafaxine in the treatment of various psychiatric conditions has not been fully elucidated; however, it is understood that venlafaxine and its active metabolite O-desmethylvenlafaxine (ODV) potently and selectively inhibits the reuptake of both serotonin and norepinephrine at the presynaptic terminal. This results in increased levels of neurotransmitters available at the synapse that can stimulate postsynaptic receptors. It is suggested that venlafaxine has a 30-fold selectivity for serotonin compared to norepinephrine: venlafaxine initially inhibits serotonin reuptake at low doses, and with higher doses, it inhibits norepinephrine reuptake in addition to serotonin. Venlafaxine and ODV are also weak inhibitors of dopamine reuptake. [1]
Interactions []
Medical side effects []
530 side effects listed on drug labels in SIDER 4.1 (venlafaxine).
- Dizziness
- Syncope
- Ejaculation disorder
- Nervousness
- Tension
- Hyperhidrosis
- Decreased appetite
- Appetite absent
- Asthenia
- Fatigue
- Constipation
- Diarrhoea
- Soft stools
- Nausea
- Pharyngitis
- Abnormal dreams
- Dreaming excessive
- Vivid dreams
- Dyspepsia
- Influenza
- Amnesia
- Arthralgia
- Musculoskeletal discomfort
- Myalgia
- Bronchitis
- Neck pain
- Confusional state
- Feeling abnormal
- Malaise
- Depersonalisation
- Dysgeusia
- Taste altered
- Dyspnoea
- Ecchymosis
- Oedema
- Body temperature increased
- Flushing
- Hypoaesthesia
- Mydriasis
- Prostatitis
- Pruritus
- Tachycardia
- Tremor
- Trismus
- Vertigo
- Weight increased
- Chills
- Migraine
- Injury
- Intentional injury
- Trauma
- Chest pain
- Accommodation disorder
- Dysuria
- Increased appetite
- Thinking abnormal
- Mental disability
- Visual impairment
- Abnormal vision
- Cough
- Blood cholesterol increased
- High cholesterol
- Menopausal symptoms
- Hot flush
- Anxiety
- Yawning
- Vasodilation procedure
- Abdominal pain
- Gastrointestinal pain
- Flatulence
- Hypertension
- Vomiting
- Erectile dysfunction
- Libido decreased
- Disturbance in sexual arousal
- Libido increased
- Depression
- Depressive disorder
- Headache
- Hypertonia
- Palpitations
- Paraesthesia
- Weight decreased
- Agitation
- Hyperkinesia
- Muscle twitching
- Anorgasmia
- Insomnia
- Somnolence
- Prostatic disorder
- Infection
- Eructation
- Sinusitis
- Dry mouth
- Albuminuria
- Alopecia
- Amenorrhoea
- Anaemia
- Angina pectoris
- Arrhythmia
- Arthritis
- Rheumatoid arthritis
- Asthma
- Ataxia
- Bruxism
- Bursitis
- Candida infection
- Oral candidiasis
- Colitis
- Conjunctivitis
- Cystitis
- Bladder pain
- Cystitis noninfective
- Dysphagia
- Dehydration
- Dermatitis contact
- Diplopia
- Eczema
- Epistaxis
- Oesophagitis
- Dermatitis
- Rash
- Gastritis
- Gastroenteritis
- Gingivitis
- Glossitis
- Hallucination
- Haematuria
- Haemorrhoids
- Hostility
- Hypercholesterolaemia
- Hyperaesthesia
- Hyperglycaemia
- Hyperlipidaemia
- Hyperventilation
- Hypokalaemia
- Hypotension
- Orthostatic hypotension
- Irritability
- Arthropathy
- Osteoarthritis
- Nephrolithiasis
- Laryngospasm
- Laryngitis
- Muscle spasms
- Cramp muscle
- Leukocytosis
- Leukopenia
- Vaginal discharge
- Breast pain
- Melaena
- Menorrhagia
- Metrorrhagia
- Hypotonia
- Muscle relaxant therapy
- Myoclonus
- Neuralgia
- Nocturia
- Orgasm abnormal
- Delayed orgasm
- Otitis media
- Pelvic pain
- Pneumonia
- Polyuria
- Urine output increased
- Psoriasis
- Psychotic disorder
- Pyuria
- Convulsion
- Stomatitis
- Mouth ulceration
- Withdrawal syndrome
- Suicide attempt
- Shock
- Loss of consciousness
- Tenosynovitis
- Thirst
- Urinary incontinence
- Urticaria
- Vaginal inflammation
- Vaginal infection
- Urinary retention
- Peripheral vascular disorder
- Pollakiuria
- Micturition urgency
- Stupor
- Depressed level of consciousness
- Apathy
- Flat affect
- Mood swings
- Affect lability
- Photophobia
- Musculoskeletal stiffness
- Nuchal rigidity
- Tongue disorder
- Tongue oedema
- Liver function test abnormal
- Mania
- Bone pain
- Eye pain
- Paraesthesia oral
- Blood alkaline phosphatase increased
- Aspartate aminotransferase increased
- Dry skin
- Photosensitivity reaction
- Discomfort
- Ill-defined disorder
- Speech disorder
- Euphoric mood
- Gastrointestinal ulcer
- Pulmonary congestion
- Respiratory tract congestion
- Rectal haemorrhage
- Dry eye
- Extrasystoles
- Ventricular bigeminy
- Akathisia
- Rash maculo-papular
- Suicidal ideation
- Peripheral coldness
- Cold feet
- Prostatomegaly
- Bradycardia
- Neuropathy peripheral
- Neuritis
- Lymphadenopathy
- Coordination abnormal
- Face oedema
- Renal pain
- Thrombocytosis
- Muscular weakness
- Parosmia
- Exostosis
- Ageusia
- Vaginal haemorrhage
- Skin hypertrophy
- Alanine aminotransferase increased
- Onychoclasis
- Abdominal distension
- Congenital anomaly
- Developmental delay
- Adjustment disorder
- Agranulocytosis
- Anaphylactic shock
- Aplastic anaemia
- Angioedema
- Anuria
- Aortic aneurysm
- Aphasia
- Appendicitis
- Sinus arrhythmia
- Arteritis
- Atelectasis
- Pneumothorax
- Atrial fibrillation
- Bacteraemia
- Balanitis
- Blepharitis
- Bundle branch block
- Capillary fragility
- Neoplasm malignant
- Cardiovascular disorder
- Catatonia
- Cellulitis
- Cervicitis
- Cheilitis
- Cholecystitis
- Cholelithiasis
- Cyanosis
- Deafness
- Delirium
- Delusion
- Dermatitis exfoliative
- Diabetes mellitus
- Duodenitis
- Dyskinesia
- Buccoglossal syndrome
- Movements involuntary
- Endometriosis
- Eosinophilia
- Toxic epidermal necrolysis
- Erythema multiforme
- Stevens-Johnson syndrome
- Erythema nodosum
- Oesophageal spasm
- Exophthalmos
- Eye haemorrhage
- VIIth nerve paralysis
- Hepatic steatosis
- Fibrocystic breast disease
- Multiple fractures
- Fracture
- Furuncle
- Gastrooesophageal reflux disease
- Gastrointestinal haemorrhage
- Gingival bleeding
- Glaucoma
- Angle closure glaucoma
- Glycosuria
- Goitre
- Gout
- Granuloma
- Guillain-Barre syndrome
- Gynaecomastia
- Cardiac arrest
- Cardiac failure congestive
- Haematemesis
- Blood disorder
- Haematoma
- Haemochromatosis
- Haemoptysis
- Haemorrhage
- Haemoglobin
- Hepatitis
- Hirsutism
- Hyperbilirubinaemia
- Hypercalciuria
- Crystalluria calcium
- Hyperkalaemia
- Hyperthyroidism
- Salivary gland enlargement
- Hypoglycaemia
- Hypomenorrhoea
- Hyponatraemia
- Hypoproteinaemia
- Hypothyroidism
- Conversion disorder
- Ileitis
- Inappropriate antidiuretic hormone secretion
- Intestinal obstruction
- Ischaemia
- Jaundice
- Keratitis
- Labyrinthitis
- Laryngeal oedema
- Lymphocytosis
- Mastitis
- Menopause
- Menstrual disorder
- Miliaria
- Miosis
- Mitral valve disease
- Motion sickness
- Plasma cell myeloma
- Plasmacytoma
- Myopathy
- Myocardial infarction
- Acute coronary syndrome
- Necrosis
- Neuroleptic malignant syndrome
- Neutropenia
- Night sweats
- Nystagmus
- Oliguria
- Orchitis
- Orchitis noninfective
- Osteoporosis
- Osteosclerosis
- Otitis externa
- Ovarian cyst
- Pallor
- Pancreatitis
- Pancytopenia
- Panic reaction
- Optic neuritis
- Papilloedema
- Paresis
- Parotitis
- Periodontitis
- Petechiae
- Pleurisy
- Polycythaemia vera
- Proctitis
- Proteinuria
- Protein urine present
- Prurigo
- Pulmonary embolism
- Pulmonary eosinophilia
- Purpura
- Vascular purpura
- Pyelonephritis
- Hyperacusis
- Anorectal disorder
- Renal failure
- Retinal haemorrhage
- Rhabdomyolysis
- Salpingitis
- Scleritis
- Scotoma
- Seborrhoeic dermatitis
- Salivary hypersecretion
- Sleep apnoea syndrome
- Sleep disorder
- Cerebrovascular accident
- Conjunctival haemorrhage
- Supraventricular tachycardia
- Thrombocytopenia
- Thrombophlebitis
- Thyroid neoplasm
- Thyroiditis
- Tinnitus
- Torsade de pointes
- Torticollis
- Azotaemia
- Uterine haemorrhage
- Uveitis
- Varicose vein
- Venous insufficiency
- Ventricular fibrillation
- Ventricular tachycardia
- Atrioventricular block first degree
- Akinesia
- Rash pustular
- Vesiculobullous rash
- Hyperphosphataemia
- Hypophosphataemia
- Breast engorgement
- Alcohol abuse
- Hypokinesia
- Cataract
- Breast discharge
- Plantar fasciitis
- Deep vein thrombosis
- Alcohol intolerance
- Skin atrophy
- Bleeding time prolonged
- Blood urea increased
- Corneal lesion
- Blood creatine phosphokinase increased
- Blood creatinine increased
- Tongue discolouration
- Conjunctival oedema
- Ventricular extrasystoles
- Hair colour changes
- Impaired healing
- Hyperchlorhydria
- Gastric pH decreased
- Hypocholesterolaemia
- Renal impairment
- Galactorrhoea
- Blood lactate dehydrogenase increased
- Hepatocellular injury
- Liver injury
- Liver tenderness
- Biliary colic
- Paranoia
- Dermatitis bullous
- Hyporeflexia
- Hyperreflexia
- Skin discolouration
- Tendon rupture
- Uterine spasm
- Skin striae
- Vitreous disorder
- Abortion
- Leukoderma
- Lichenoid keratosis
- Interstitial lung disease
- Bradykinesia
- Extrapyramidal disorder
- Vulvovaginal dryness
- Hypomania
- Major depression
- Influenza like illness
- Calculus urinary
- Homicidal ideation
- Energy increased
- Chromatopsia
- Dementia
- Feeling drunk
- Hypohidrosis
- Blood prolactin increased
- Gait disturbance
- Tardive dyskinesia
- Drug interaction
- Serotonin syndrome
- Basophilia
- Blood uric acid increased
- Hyperuricaemia
- Cerebral ischaemia
- Epidermal necrosis
- Coronary artery disease
- Breast enlargement
- Erection increased
- Hypoxia
- Respiratory failure
- Hypoventilation
- Aggression
- Anxiety disorder
- Back pain
- Cyst
- Dysthymic disorder
- Dysmenorrhoea
- Electric shock
- Muscle contractions involuntary
- Breath odour
- Cardiac disorder
- Hiccups
- Hypersensitivity
- Lung disorder
- Nightmare
- Pain
- Rhinitis
- Completed suicide
- Unintended pregnancy
- Erythema
- Upper respiratory tract infection
- Congenital genitourinary abnormality
- Skin odour abnormal
- High density lipoprotein decreased
- Low density lipoprotein increased
- Dysphoria
- Abnormal behaviour
- Ejaculation delayed
- Sputum increased
- Increased bronchial secretion
- Urine abnormality
- Urine analysis abnormal
- Drug tolerance
- Blood pressure diastolic increased
- Drug dependence
- Drug seeking behavior
- Hepatitis fulminant
- Vision blurred
- Difficulty focusing eyes
- Dependence
- Grand mal convulsion
- Blood pressure increased
- Sexual dysfunction
- Loss of libido
Indications
- Abdominal distress
- Agitation
- Agoraphobia
- Anxiety
- Bradypsychic response
- Cerebration impaired
- Chest pain
- Chills
- Choking sensation
- Decreased interest
- Depersonalisation
- Depressed mood
- Depression
- Derealisation
- Discomfort
- Distress
- Dizziness
- Drug abuse
- Dysphoria
- Dyspnoea
- Fatigue
- Fear of death
- Feeling guilty
- Generalised anxiety disorder
- Heart pounding
- Hot flush
- Hypersomnia
- Insomnia
- Irritability
- Lightheadedness
- Major depression
- Major depressive disorder, single episode
- Melancholia
- Nausea
- Numbness
- Palpitations
- Panic attack
- Panic disorder
- Paraesthesia
- Performance fear
- Phobia
- Sexual dysfunction
- Sickness
- Sleep disturbance
- Social phobia
- Suicidal ideation
- Suicide attempt
- Sweating
- Tension
- Tingling sensation
- Trembling
Subjective effects []
| a1ko / Venlafaxine [] | |
|---|---|
Routes:
| |
| Pilz / Venlafaxine [] | |
|---|---|
Routes:
| |
Experience reports
Legal status []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 5656, Venlafaxine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/5656
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Venlafaxine. UNII: GRZ5RCB1QG. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GRZ5RCB1QG
Dean L. Venlafaxine Therapy and CYP2D6 Genotype. National Center for Biotechnology Information (US). 2015. https://www.ncbi.nlm.nih.gov/books/NBK305561/#:~:text=Venlafaxine%20is%20metabolized%20into%20its,reduced%20or%20absent%20CYP2D6%20activity.
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 31 March 2023. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Efexor XL 75 mg hard prolonged release capsules - Summary of Product Characteristics (SmPC). (emc). 16 March 2020. https://www.medicines.org.uk/emc/product/5474/smpc
Effexor XR- venlafaxine hydrochloride capsule, extended release. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=53c3e7ac-1852-4d70-d2b6-4fca819acf26
Venlafaxine tablet, extended release. DailyMed. 30 June 2022. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e81a2daf-b8b2-7c05-b532-bc775700b100
Opinion following an Article 30 referral for Efexor and associated names International Non-Proprietary Name (INN): venlafaxine: Background information. European Medicines Agency. 12 March 2008. https://www.ema.europa.eu/en/documents/referral/efexor-article-30-referral-annex-i-ii-iii_en.pdf
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | ok | 2026-11-20 12:32:54 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 12:32:49 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 12:32:49 |
| gsrs | ok | 2026-11-20 12:32:51 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0005016) | 2026-11-20 12:32:49 |
| kegg | ok | 2026-11-20 12:32:52 |
| pubchem | ok | 2026-11-20 12:32:48 |
| ok | 2026-11-20 12:32:49 | |
| sider | ok | 2026-11-20 12:32:50 |
| structure | ok | 2026-11-20 12:32:49 |
| wikipedia | ok | 2026-11-20 12:32:50 |